BPL1® Postbiotic

As an innovative leader in the microbiome field, ADM delivers future-forward nutrition fueled by science, with a complete range of solutions from prebiotics to probiotic and postbiotic strains, all clinically documented to deliver health & wellness benefits. BPL1® Postbiotic (Bifidobacterium lactis) is ADM’s proprietary, award-winning postbiotic strain with clinically documented results in supporting aspects related to metabolic health. BPL1® postbiotic is backed by ADM’s gold-standard human clinical trial and is currently being investigated in additional human clinical trials, with emerging and in vitro evidence that supplementation may help support Visceral fat reduction in combination with diet and exercise, A healthy waist circumference in conjunction with diet and exercise, Metabolic health pathways. BPL1® Postbiotic is the winner of Awards in 2020 as Ingredient of the Year in Weight Management. Postbiotics represent a massive step forward in the ability to support metabolic health, offering unique benefits as they offer unparalleled stability. BPL1® Postbiotic is heat treated ingredient and can be used in a wide variety of food & beverages and food supplements regardless of moisture content, heat, pressure and other challenging manufacturing conditions. Pedret A; et al. (2019) Int J Obes. 43(9): 1863‐1868 This communication is intended for B2B use and no statements are meant to be perceived as approved by regulatory authorities. Local regulations must be reviewed to confirm permissibility of ingredients and claims for each food category.